Nucleotide-binding oligomerization domain-containing protein 1 regulates inflammatory response in endometriosis
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study found that Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) is elevated in endometriosis and positively correlates with inflammatory cytokines, with ML130 treatment suppressing cell viability and cytokine production in ectopic endometrial stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) is known to play an important role in innate immunity, while the relationship between NOD1 and inflammatory response in endometriosis remains unknown. The present study aims to investigate the effects of NOD1 on inflammatory response in endometriosis. METHODS: Immunohistochemistry staining, Western blot, and qRT-PCR were conducted to investigate the levels of NOD1 and inflammatory cytokines in the endometriotic lesions. A Spearman's rank correlation analysis was conducted to determine the correlations of NOD1 and inflammatory cytokines (interleukin (IL)-6, tumor necrosis factor (TNF)-α, and monocyte chemoattractant protein (MCP)-1). Human endometrial stromal cells (HESCs) were isolated and incubated with peritoneal fluid with or without ML130. Cell viability was determined by using an MTT assay. RESULTS: A significant elevation in NOD1 and inflammatory cytokine was observed in ectopic endometrium. Interestingly, a positive correlation between NOD1 and inflammatory cytokines was observed. In addition, treatment with ML130 significantly suppressed cell viability and the production of inflammatory cytokines in the 20% peritoneal fluid treated ectopic HESCs. CONCLUSIONS: NOD1 is related to the inflammatory response that is involved in endometriosis.
Full text
3,382 characters
· extracted from
oa-doi-fallback
· 5 sections
· click to expand
Abstract
Background: Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) is known to play an important role in innate immunity, while the relationship between NOD1 and inflammatory response in endometriosis remains unknown. The present study aims to investigate the effects of NOD1 on inflammatory response in endometriosis.
Methods
Immunohistochemistry staining, Western blot, and qRT-PCR were conducted to investigate the levels of NOD1 and inflammatory cytokines in the endometriotic lesions. A Spearman’s rank correlation analysis was conducted to determine the correlations of NOD1 and inflammatory cytokines (interleukin (IL)-6, tumor necrosis factor (TNF)-α, and monocyte chemoattractant protein (MCP)-1). Human endometrial stromal cells (HESCs) were isolated and incubated with peritoneal fluid with or without ML130. Cell viability was determined by using an MTT assay.
Results
A significant elevation in NOD1 and inflammatory cytokine was observed in ectopic endometrium. Interestingly, a positive correlation between NOD1 and inflammatory cytokines was observed. In addition, treatment with ML130 significantly suppressed cell viability and the production of inflammatory cytokines in the 20% peritoneal fluid treated ectopic HESCs.
Conclusions
NOD1 is related to the inflammatory response that is involved in endometriosis.
Keywords
Endometriosis, endometrial stromal cells, inflammation, NOD1, ML130, tumor necrosis factor.
[http://dx.doi.org/10.1093/humupd/dmq050] [PMID: 21106492]
[http://dx.doi.org/10.2165/00003495-200969060-00002] [PMID: 19405548]
[http://dx.doi.org/10.1016/j.ogc.2012.10.002] [PMID: 23182559]
[http://dx.doi.org/10.1111/j.1751-486X.2008.00362.x] [PMID: 18837717]
[http://dx.doi.org/10.1196/annals.1335.032] [PMID: 15731321]
[http://dx.doi.org/10.2741/4431] [PMID: 27100482]
[http://dx.doi.org/10.1016/j.gmit.2015.05.001]
[http://dx.doi.org/10.3109/09513590.2010.507292] [PMID: 20712428]
[http://dx.doi.org/10.1034/j.1600-0897.2003.01207.x] [PMID: 12854733]
[http://dx.doi.org/10.1111/j.1600-0897.2010.00920.x] [PMID: 20825374]
[http://dx.doi.org/10.1158/0008-5472.CAN-08-2061] [PMID: 19074871]
[http://dx.doi.org/10.1074/jbc.M501649200] [PMID: 16150702]
[http://dx.doi.org/10.1038/sj.cdd.4402070] [PMID: 17186025]
[http://dx.doi.org/10.1152/ajpendo.00709.2010] [PMID: 21693690]
[http://dx.doi.org/10.3389/fimmu.2012.00328] [PMID: 23162548]
[http://dx.doi.org/10.1016/j.abb.2018.12.022] [PMID: 30578751]
[http://dx.doi.org/10.1177/1933719113497280] [PMID: 23885104]
[http://dx.doi.org/10.1530/REP-16-0643] [PMID: 28348069]
[http://dx.doi.org/10.1038/nri1747] [PMID: 16493424]
[http://dx.doi.org/10.1093/molehr/gap020] [PMID: 19273470]
[http://dx.doi.org/10.1210/en.2005-0426] [PMID: 16195411]
[http://dx.doi.org/10.1034/j.1600-0897.2003.00028.x] [PMID: 12765345]
[http://dx.doi.org/10.1016/S0015-0282(16)57506-2] [PMID: 7890085]
[http://dx.doi.org/10.1016/j.molmed.2018.07.004] [PMID: 30054239]
[http://dx.doi.org/10.1586/eci.11.53] [PMID: 21895474]
[http://dx.doi.org/10.1016/j.ejphar.2017.01.019] [PMID: 28104349]
[http://dx.doi.org/10.2741/e358] [PMID: 22201853]
[http://dx.doi.org/10.1186/s12905-019-0865-4] [PMID: 31906916]
[http://dx.doi.org/10.1016/j.intimp.2016.08.024] [PMID: 27588911]
[http://dx.doi.org/10.1016/0303-7207(94)03442-V] [PMID: 7768330]
[http://dx.doi.org/10.1016/S0015-0282(16)57733-4] [PMID: 7542208]
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-08-09T06:10:49.860119+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-22T00:35:11.618910+00:00
- unpaywall
- last seen: 2026-08-09T06:42:26.407065+00:00
License: CC0
· commercial use OK